Next, using paired MTAP-intact and MTAP-deficient cell lines, we established that MTAP-deficient GBM cells display increased resistance to TMZ (Figure S4A,B), agreeing with our previous finding [12]. The gene discussed is MTAP; the disease is glioblastoma.